SCHEMBL13623237

SCHEMBL13623237

c1ccc2c(c1)Oc1ccc(-c3ccc(-c4ccc5c(c4)N(c4ccc6ccccc6c4)c4ccccc4O5)cc3)cc1N2c1ccc2ccccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
LPL P06858 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
MAPK10 P53779 3/20 0.35
MAPK9 P45984 2/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR3A P46098 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18770792 0.89 HSP90AA1 (0.50) HSP90AA1MAPTSMN1; SMN2NPSR1MAPK10
SCHEMBL13623247 0.89 HSP90AA1 (0.38) HSP90AA1MAPTSMN1; SMN2NPSR1MAPK10
SCHEMBL13623249 0.89 HSP90AA1 (0.38) HSP90AA1MAPTSMN1; SMN2NPSR1MAPK10
SCHEMBL22961348 0.85 SMN1; SMN2 (0.42) HSP90AA1MAPTSMN1; SMN2NPSR1ESR1
SCHEMBL20707402 0.84 HSP90AA1 (0.33) HSP90AA1MAPTSMN1; SMN2NPSR1ESR1
SCHEMBL20707432 0.84 HSP90AA1 (0.33) HSP90AA1MAPTSMN1; SMN2NPSR1ESR1
SCHEMBL23220436 0.84 HSP90AA1 (0.42) HSP90AA1MAPTSMN1; SMN2ESR1ESR2
SCHEMBL18542230 0.83 ESR1 (0.41) MAPTSMN1; SMN2ESR1ESR2LPL
SCHEMBL23220417 0.83 HSP90AA1 (0.45) HSP90AA1MAPTSMN1; SMN2ESR1ESR2
SCHEMBL13623242 0.83 P2RX4 (0.38) HSP90AA1MAPTSMN1; SMN2NPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R HSP90AA1 4725/4885MAPT 3866/4885SMN1; SMN2 4436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.